Chen, Q.Y., Jiao, D.M., Yao, Q.H., Yan, J., Song, J., Chen, F.Y., Lu, G.H. and Zhou, J.Y. (2012) Expression Analysis of Cdc42 in Lung Cancer and Modulation of Its Expression by Curcumin in Lung Cancer Cell Lines. International Journal of Oncology, 40, 1561-1568.

has been cited by the following article:

• TITLE: Multiple Actions of Curcumin Including Anticancer, Anti-Inflammatory, Antimicrobial and Enhancement via Cyclodextrin

  AUTHORS: Aaron J. Smith, John Oertle, Dino Prato

  KEYWORDS: Curcumin, Cancer, Chemotherapy, Anti-Inflammatory, Antimicrobial, Cyclodextrin

  JOURNAL NAME: Journal of Cancer Therapy, Vol.6 No.3, March 17, 2015

  ABSTRACT: Curcumin is a naturally occurring phytotherapeutic that has broad uses including the treatment of cancer and as a potent antimicrobial agent. Its dynamic ability to treat very different kinds of disease has spawned a significant increase in inquiry on how curcumin accomplishes these feats. Thousands of peer reviewed papers were published in the past few years regarding the various functions of curcumin. Unlike most pharmaceuticals, curcumin has a multi-range of different targets that it interacts with. Since curcumin’s bioavailabilty is limited, methods of increasing curcumin’s bioavailabilty are discussed. Mechanisms of action regarding curcumin’s ability to effect cancer are discussed including upstream and downstream mechanisms starting with epigenetics to its effect on signal transduction pathways and apoptosis. Curcumin also works adjuvantly with chemotherapy to reduce resistance and enhance the mechanism of certain chemotherapeutic agents. Curcumin’s antibacterial, antifungal, and antiviral capability is also discussed with regard to curcumin’s dynamic ability to treat infections. Curcumin use in cancer adjunctive care and its anti-infectious capabilities make it a unique phytotherapeutic agent with promise.